| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/11/2002 | US20020091074 Medical compositions, dressings and methods for treating microbial infections of skin lesions |
| 07/11/2002 | US20020090721 Mucin-containing delivery vehicle for the transport of biomolecules |
| 07/11/2002 | US20020090659 Detection and visualization of neoplastic tissues and other tissues |
| 07/11/2002 | US20020090419 Food formulations with a high calcium content |
| 07/11/2002 | US20020090398 Flowable, biocompatible, branched thermoplastic polymer used to form solid matrices such as implants and controlled-release, drug-formulations in a body |
| 07/11/2002 | US20020090397 Novel suppository form comprising an acid-labile active compound |
| 07/11/2002 | US20020090396 Administering a sustained release pharmaceutical dosage form including ranolazine for therapy of cardiovascular disease selected from arrhythmias, variant and exercise-induced angina, and myocardial infarction |
| 07/11/2002 | US20020090390 Device and method for treating urinary incontinence in females |
| 07/11/2002 | US20020090387 Insecticidal combination to control mammal fleas in particular fleas in particular fleas on cats and dogs |
| 07/11/2002 | US20020090383 Phosphatidyl oligoglycerols |
| 07/11/2002 | US20020090377 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | US20020090345 Dry powder inhalation formulations which are capable of providing a slow, continuous release of drug while also being biodegradable or expellable from the pulmonary or nasal tract; bioavailability |
| 07/11/2002 | US20020090340 B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging |
| 07/11/2002 | DE10131404A1 Stabilized liquid formulation, useful as a pharmaceutical composition or diagnostic reagent, comprises blood coagulation Factor VII activating protease and an aminoacid or derivative, e.g. ornithine or creatine, as stabilizer |
| 07/11/2002 | DE10064870A1 Schwefelhaltige Amphiphile für den Transfer von biologisch aktiven Molekülen in Zellen Sulfur-containing amphiphiles for the transfer of biologically active molecules into cells |
| 07/11/2002 | DE10064219A1 Neue pharmazeutische Zusammensetzung von wasserlöslichen oder schwer wasserlöslichen Wirkstoffen New pharmaceutical composition of water-soluble or poorly water-soluble drugs |
| 07/11/2002 | DE10064195A1 Verwendung einer Zusammensetzung zur Stimulation des Nervenwachstums, zur Inhibition der Narbengewebsbildung und/oder Reduktion eines Sekundärschadens Use of a composition for the stimulation of nerve growth, to inhibition of scar tissue formation and / or reduction of secondary damage |
| 07/11/2002 | CA2680475A1 Sustained-release preparation |
| 07/11/2002 | CA2435484A1 Medicinal association of a biguanide (metformin) and a carrier agent (arginine) |
| 07/11/2002 | CA2435483A1 Use as medicine of a compound restoring active principles in vivo |
| 07/11/2002 | CA2433967A1 Anti-inflammatory use of polycationic compounds |
| 07/11/2002 | CA2433794A1 Uses for polycationic compounds as vaccine adjuvants |
| 07/11/2002 | CA2433606A1 Amphipathic peptides and their use for transferring substances of interest into cells |
| 07/11/2002 | CA2433361A1 Controlled release systems for polymers |
| 07/11/2002 | CA2433332A1 Agents and methods for treating pain |
| 07/11/2002 | CA2433263A1 Stabilized pharmaceutical composition in lyophilized form |
| 07/11/2002 | CA2432184A1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 07/11/2002 | CA2432136A1 Pharmaceutical emulsion preparation |
| 07/11/2002 | CA2431853A1 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
| 07/11/2002 | CA2431413A1 Stable skin conditioning compositions containing retinoid boosters |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220902A2 Conjugates between a peptide and a nucleic acid analog, such as a pna, lna or a morpholino |
| 07/10/2002 | EP1220887A1 Protein-containing granules and granule formulations |
| 07/10/2002 | EP1220849A2 Bicyclic compounds composition and method for stabilizing the same |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220693A1 Formulations for delivery of osteogenic proteins |
| 07/10/2002 | EP1220690A2 Injection vehicle for polymer-based formulations |
| 07/10/2002 | EP1220688A1 Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes |
| 07/10/2002 | EP1220685A2 Pharmaceutical compositions of fibrinolytic agent |
| 07/10/2002 | EP1220683A2 Mycophenolate mofetil in association with peg-ifn-alpha |
| 07/10/2002 | EP1220682A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 07/10/2002 | EP1220677A1 Iodine containing antimicrobial compositions for mastitis control |
| 07/10/2002 | EP1220670A1 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 07/10/2002 | EP1220667A2 Treating endometriosis or infertility, or improving fertility |
| 07/10/2002 | EP1220663A1 Superficial therapeutic system for topically applying acetylsalicylic acid, for the treatment of acne-related diseases |
| 07/10/2002 | EP1220662A1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 07/10/2002 | EP1220661A2 Transdermal therapeutic system for administering acetylsalicylic acid and/or salicylic acid |
| 07/10/2002 | EP1220660A1 Tablets with a gellan gum coating |
| 07/10/2002 | EP1220659A1 Pharmaceutical products and methods of fabrication therefor |
| 07/10/2002 | EP1220658A1 Melt granulated composition and modified release dosage form prepared from said composition |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP1220656A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 07/10/2002 | EP1063942A4 Liquid polymeric compositions for controlled release of bioactive substances |
| 07/10/2002 | EP0967967B1 Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin |
| 07/10/2002 | EP0949929B1 Use of plant extract for inhibition of haemophilus influenzae |
| 07/10/2002 | EP0938339B1 Formulations for topical use containing vit. e acetate |
| 07/10/2002 | CN1358233A Oligosaccharide-supplying compositions |
| 07/10/2002 | CN1358225A Cleaning compositions and tablets |
| 07/10/2002 | CN1358197A Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 07/10/2002 | CN1358171A Valency platform molecules comprising aminooxy groups |
| 07/10/2002 | CN1358164A Branched largely insatured fatty alcohols |
| 07/10/2002 | CN1358090A Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 07/10/2002 | CN1358089A Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same |
| 07/10/2002 | CN1358088A Pharmaceuticla dosage forms for controlled telease producing at least timed pulse |
| 07/10/2002 | CN1358087A Timed dual release dosage forms comprising short acting hypnotic or salt thereof |
| 07/10/2002 | CN1358086A Ophthalmic composition comprising retotifen |
| 07/10/2002 | CN1358063A Effervescent green tea extract formulation |
| 07/10/2002 | CN1357386A Prepn process of nano-granule medicine carrier with chitin and its derivative |
| 07/10/2002 | CN1087317C Block polymer having functional groups at both ends |
| 07/10/2002 | CN1087293C New amino alcohol derivatives, process for production thereof and medicaments and reagents containing these compounds |
| 07/10/2002 | CN1087178C Isotopic urea tablets |
| 07/10/2002 | CN1087176C Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
| 07/10/2002 | CN1087169C Anti-inflammatory eyedrops |
| 07/09/2002 | US6417339 Core, spacers |
| 07/09/2002 | US6417237 Macromolecular drug complexes and compositions containing the same |
| 07/09/2002 | US6417234 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 07/09/2002 | US6417196 Stabilization of quinapril using magnesium oxide |
| 07/09/2002 | US6417180 Zinc finger-reactive antimicrobial compounds |
| 07/09/2002 | US6417177 Chloroquine derivatives for the treatment of Parkinson's disease |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417170 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance dna repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells |
| 07/09/2002 | US6417167 Lyophilized compositions containing shingoglycolipid and process for preparing them |
| 07/09/2002 | US6417144 Amino acid type cationic surfactant and at least one nonionic surfactant. |
| 07/09/2002 | US6416960 Detection and visualization of neoplastic tissues and other tissues |
| 07/09/2002 | US6416947 Vaccine adjuvant and vaccine method |
| 07/09/2002 | US6416945 Disassembling virus-like particles of l1 proteins or mixture of l1 and l2 proteins by contacting for prolonged time period with concentrated reducing agent solution, adding moiety to be encapsulated, reassembling by removing reducing agent |
| 07/09/2002 | US6416787 Extruding, at elevated temperature, a composition comprising a starch, water, a thermostable enzyme, and a drug; the porous extrudate is capable of disintegration when exposed to an aqueous environment. |
| 07/09/2002 | US6416786 Sustained release tablet containing hydrocolloid and cellulose ether |
| 07/09/2002 | US6416779 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 07/09/2002 | US6416772 Comprising an alcohol, glycerin, an analgesic agent comprising salicylic acid, methylsulfonylmethane, emu oil |
| 07/09/2002 | US6416767 Use of peroxidized lipids as agents intended to prevent and/or to treat the irritant effects of an active principle |
| 07/09/2002 | US6416762 Anti-picornaviral ligands via a combinatorial computational and synthetic approach |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | US6416757 Tumor necrosis factor antibodies |
| 07/09/2002 | US6416743 Nontoxic, stable formulation free of chlorofluorocarbons; surfactant and excipient free |
| 07/09/2002 | US6416742 Medicinal aerosol solution formulation with biocompatible polymer |
| 07/09/2002 | US6416741 Preparation of further diagnostic agents |
| 07/09/2002 | US6416740 Acoustically active drug delivery systems |